Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Axogen, Inc. Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$83.4 Billion
Q1 2025

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 14, 2018	SELL	$36.15 - $52.5 $966,795 - $1.4 Million	-26,744 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $652,553 - $1.08 Million	26,744 New	26,744 $976,000

Others Institutions Holding AXGN

# of Institutions

191

Shares Held

39.2M

Call Options Held

61.7K

Put Options Held

42.8K

First Light Asset Management, LLC Edina, MN

4.47M
Shares

$43.7 Million
10.62% of portfolio
Black Rock Inc. New York, NY

3.25M
Shares

$31.7 Million
0.0% of portfolio
Morgan Stanley New York, NY

2.6M
Shares

$25.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.54M
Shares

$24.8 Million
0.0% of portfolio
Arrow Mark Colorado Holdings LLC Denver, CO

1.59M
Shares

$15.5 Million
0.54% of portfolio

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $413M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account